bioresearch-filters-purificationFeaturedArticles

  1. Neutralizing Drone Swarms With Radio Waves 1/10/2025

    The RFDEW is designed to detect, track, and neutralize threats across land, air, and sea with near-instantaneous effects at distances of more than half a mile, costing about 13 cents per shot.

  2. Radar Antennas: Applications, Types, And Market Dynamics 2/21/2024

    Radar antennas play a vital role in various applications such as weather forecasting, traffic control, and military operations. Current market growth is being driven by increasing demand across industries, advancements in technology leading to more efficient and eco-friendly options, and government regulations. Let’s take a closer look at these unsung heroes of modern radar systems.

  3. Seriously … Are We Making Any Progress? 9/25/2025

    Ken Getz’s DPHARM talk revealed how ballooning data collection in trial protocols drives costs, delays, and site burden. New ICH E6 R3 guidance pushes for simpler, more flexible designs, but real progress will require collaboration — and restraint.

  4. A Closer Look At How RBQM Has Evolved In Recent Years 1/29/2024

    Mary Arnould, senior director, program management/RBM lead, Clinical Science Operations at Astellas, talks about her SCOPE Summit 2024 presentation called “COVID-19 Pandemic Impact on Risk-Based Quality Management.”

  5. Lilly's CEO Building On The Trump Agenda 5/12/2025

    “We hadn’t built a new site in the U.S. in more than 40 years until the first set of Trump tax cuts, so we need to see those either extended or improved to support this,” Eli Lilly CEO David Ricks recently said, announcing — in Washington, DC — plans to invest $27 billion to build four new manufacturing plants in the U.S.

  6. Out In The Neon Light: Quantum Sensing's New Dawn For Photonics 5/15/2025

    Recent quantum breakthroughs overcome decoherence and enable mass production, driving photonics innovation across medical and environmental applications.

  7. What's In Your DMF? 7/8/2024

    Are relevant Drug Master Files (DMFs) at your CDMO in good order or fully under consideration as part of your upcoming new-drug submissions to the FDA or other agencies? “I've lived with this on both sides, as an FDA official and at biopharma organizations,” says Ben Stevens, Director CMC Policy and Advocacy, GSK, and former  Branch Chief / Chemistry Reviewer at FDA. Here's what he advises.

  8. A Couple's Plan To Revamp Poland's Clinical Trial System 6/11/2024

    Hanna and Artur Preus collected and analyzed 3,208 questionnaires from patients, pharma companies, CROs, site staff, and private companies to identify the shortcomings in the Polish clinical trials system and then make recommendations on how to improve it.

  9. RNAi vs. mRNA: Two Therapies, Two CDMO Strategies 7/1/2025

    The biotech industry is often described in grand dichotomies such as innovator vs. generic, small vs. large molecule, or clinical vs. commercial. These differentiators influence development and manufacturing, CDMO selection and outsourcing strategies. There are also nuanced pairings, such as mRNA vs. RNAi.

  10. BIO2025 Recap: FDA Reducing Animal Testing, Governor Shapiro On Supporting Biopharma, Practical AI Use 6/24/2025

    Bioprocess Online chief editor Tyler Menichiello shares his three key takeaways from the 2025 BIO International Convention.